IL162527A0 - Novel fluorene carboxylic acid esters, methods forthe production thereof, and use of the same as pharmaceuticals - Google Patents

Novel fluorene carboxylic acid esters, methods forthe production thereof, and use of the same as pharmaceuticals

Info

Publication number: IL162527A0
Authority: IL; Israel
Prior art keywords: pharmaceuticals; carboxylic acid; same; acid esters; forthe production
Prior art date: 2002-01-31

Application number

IL16252703A

Other languages

English (en)

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-31

Filing date

2003-01-21

Publication date

2005-11-20

2003-01-21 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2005-11-20 Publication of IL162527A0 publication Critical patent/IL162527A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Neurology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL16252703A 2002-01-31 2003-01-21 Novel fluorene carboxylic acid esters, methods forthe production thereof, and use of the same as pharmaceuticals IL162527A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10203741A DE10203741A1 (de)	2002-01-31	2002-01-31	Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
PCT/EP2003/000534 WO2003064419A1 (fr)	2002-01-31	2003-01-21	Nouveaux esters d'acide carboxylique de fluorene, procede permettant de les produire et leur utilisation comme medicaments

Publications (1)

Publication Number	Publication Date
IL162527A0 true IL162527A0 (en)	2005-11-20

Family

ID=27588159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16252703A IL162527A0 (en)	2002-01-31	2003-01-21	Novel fluorene carboxylic acid esters, methods forthe production thereof, and use of the same as pharmaceuticals

Country Status (28)

Country	Link
EP (2)	EP1561751A1 (fr)
JP (1)	JP4484522B2 (fr)
KR (1)	KR100950869B1 (fr)
CN (1)	CN100348598C (fr)
AR (1)	AR038379A1 (fr)
AT (1)	ATE299880T1 (fr)
AU (1)	AU2003210172C1 (fr)
BR (1)	BR0307294A (fr)
CA (1)	CA2472149C (fr)
DE (2)	DE10203741A1 (fr)
EA (1)	EA006966B1 (fr)
EC (1)	ECSP045209A (fr)
ES (1)	ES2245443T3 (fr)
HR (1)	HRP20040690B1 (fr)
IL (1)	IL162527A0 (fr)
ME (1)	MEP43408A (fr)
MX (1)	MXPA04007245A (fr)
MY (1)	MY134582A (fr)
NO (1)	NO328929B1 (fr)
NZ (1)	NZ534784A (fr)
PE (1)	PE20031029A1 (fr)
PL (1)	PL209037B1 (fr)
PT (1)	PT1472251E (fr)
RS (1)	RS50918B (fr)
TW (1)	TWI352077B (fr)
UA (1)	UA78544C2 (fr)
UY (1)	UY27633A1 (fr)
WO (1)	WO2003064419A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1651208A1 (fr) *	2003-07-28	2006-05-03	Boehringer Ingelheim International GmbH	Medicaments comprenant des inhibiteurs de pde iv et un nouvel anticholinergique, et leur utilisation pour le traitement de troubles respiratoires
ES2326320T3 (es) *	2003-07-28	2009-10-07	Boehringer Ingelheim International Gmbh	Medicamentos para inhalacion que comprenden esteroides y nuevo ester del acido fluorencarboxilico.
EP1651221B1 (fr) *	2003-07-28	2009-01-14	Boehringer Ingelheim International Gmbh	Medicaments pour inhalation comportant des agents a activite betamimetique et anticholinergique
EP1651224B1 (fr) *	2003-07-31	2011-10-05	Boehringer Ingelheim International GmbH	Medicaments pour inhalation comportant un agent a activite anticholinergique et un betamimetique
DE102004001607A1 (de) *	2004-01-09	2005-08-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkombinationen auf der Basis von Scopin- oder Tropensäureestern mit EGFR-Kinase-Hemmern
EP1718301A1 (fr) *	2004-02-20	2006-11-08	Boehringer Ingelheim International GmbH	Compositions pharmaceutiques a base d'anticholinergiques et de pegsunercept
US7507745B2 (en) *	2004-02-20	2009-03-24	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
DE102004016179A1 (de) *	2004-03-30	2005-10-20	Boehringer Ingelheim Pharma	Verbindungen zur Behandlung von proliferativen Prozessen
US20060034776A1 (en) *	2004-08-10	2006-02-16	Boehringer Ingelheim International Gmbh	Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics
DE102004038885A1 (de) *	2004-08-10	2006-02-23	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
ES2322148T3 (es) *	2004-08-11	2009-06-17	BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG	Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
DE102005001297A1 (de) *	2005-01-12	2006-07-20	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
WO2006087316A1 (fr) *	2005-02-16	2006-08-24	Boehringer Ingelheim International Gmbh	Compositions pharmaceutiques comprenant des anticholinergiques et de l’etiprednol
WO2006094924A2 (fr) *	2005-03-09	2006-09-14	Boehringer Ingelheim International Gmbh	Nouvelles compositions pharmaceutiques a base d'anticholinergiques et d'inhibiteurs de pde 5
WO2006128847A2 (fr) *	2005-05-31	2006-12-07	Boehringer Ingelheim International Gmbh	Nouvelles combinaisons medicamenteuses pour le traitement de maladies respiratoires
DE102005030733A1 (de)	2005-07-01	2007-01-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
US7423146B2 (en)	2005-11-09	2008-09-09	Boehringer Ingelheim International Gmbh	Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
EP2051714B1 (fr)	2006-08-07	2011-04-13	Boehringer Ingelheim International GmbH	Combinaisons de médicaments pour le traitement des infections des voies respiratoires
UY30550A1 (es)	2006-08-22	2008-03-31	Boehringer Ingelheim Int	Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
EP1925296A1 (fr) *	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Formule de poudre stable contenant un nouveau anticholinergique
EP1997819A1 (fr) *	2007-05-25	2008-12-03	Boehringer Ingelheim Pharma GmbH & Co. KG	Procédé destiné à la fabrication d'esters de scopine
ES2569359T3 (es)	2007-07-06	2016-05-10	Vectura Delivery Devices Limited	Inhalador
EP2180892A2 (fr) *	2007-07-18	2010-05-05	Boehringer Ingelheim International GmbH	Combinaisons contenant telmisartan et un agent anticholinergique comme le tiotropium ou un sel de glycopyrrionium pour le traitement de maladies respiratoires comme le bpco ou l'asthma
EP2082766A1 (fr)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Formation d'une spirale de bande alvéolée
EP2082768A1 (fr)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhalateur
EP2082767A1 (fr)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhalateur
EP2082772A1 (fr)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhalateur
EP2082771A1 (fr)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhalateur
EP2093219A1 (fr)	2008-02-22	2009-08-26	Boehringer Ingelheim International Gmbh	Forme de sel à énantiomère pur et cristalline d'un bêtamimétique et son utilisation comme médicament
GB0918450D0 (en)	2009-10-21	2009-12-09	Innovata Ltd	Composition
CN102876318B (zh) *	2012-09-28	2014-07-16	宁波大学	一种芴羧酸酯荧光材料及其制备方法
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
KR20200067170A (ko)	2017-10-05	2020-06-11	풀크럼 쎄러퓨틱스, 인코포레이티드	FSHD의 치료를 위하여 DUX4 및 하류 유전자 발현을 저감시키는 p38 키나제 저해제

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2221828A (en) *	1936-04-25	1940-11-19	Merck & Co Inc	Esters of amino alcohols with 9-hydroxyfluorene-9-carboxylic acid and processes for their production
DE4108393A1 (de) *	1991-03-15	1992-09-17	Boehringer Ingelheim Kg	Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln

2002
- 2002-01-31 DE DE10203741A patent/DE10203741A1/de not_active Withdrawn
2003
- 2003-01-21 AU AU2003210172A patent/AU2003210172C1/en not_active Ceased
- 2003-01-21 AT AT03734600T patent/ATE299880T1/de active
- 2003-01-21 RS YUP-656/04A patent/RS50918B/sr unknown
- 2003-01-21 CN CNB038030004A patent/CN100348598C/zh not_active Expired - Fee Related
- 2003-01-21 IL IL16252703A patent/IL162527A0/xx not_active IP Right Cessation
- 2003-01-21 EP EP05004525A patent/EP1561751A1/fr not_active Withdrawn
- 2003-01-21 ES ES03734600T patent/ES2245443T3/es not_active Expired - Lifetime
- 2003-01-21 HR HRP20040690AA patent/HRP20040690B1/xx not_active IP Right Cessation
- 2003-01-21 ME MEP-434/08A patent/MEP43408A/xx unknown
- 2003-01-21 UA UA20040807067A patent/UA78544C2/uk unknown
- 2003-01-21 KR KR1020047011881A patent/KR100950869B1/ko not_active Expired - Fee Related
- 2003-01-21 PT PT03734600T patent/PT1472251E/pt unknown
- 2003-01-21 MX MXPA04007245A patent/MXPA04007245A/es active IP Right Grant
- 2003-01-21 JP JP2003564042A patent/JP4484522B2/ja not_active Expired - Lifetime
- 2003-01-21 WO PCT/EP2003/000534 patent/WO2003064419A1/fr not_active Ceased
- 2003-01-21 EA EA200400878A patent/EA006966B1/ru not_active IP Right Cessation
- 2003-01-21 DE DE50300813T patent/DE50300813D1/de not_active Expired - Lifetime
- 2003-01-21 BR BR0307294-0A patent/BR0307294A/pt not_active Application Discontinuation
- 2003-01-21 EP EP03734600A patent/EP1472251B1/fr not_active Expired - Lifetime
- 2003-01-21 PL PL369396A patent/PL209037B1/pl unknown
- 2003-01-21 NZ NZ534784A patent/NZ534784A/en not_active IP Right Cessation
- 2003-01-21 CA CA2472149A patent/CA2472149C/fr not_active Expired - Fee Related
- 2003-01-29 MY MYPI20030303A patent/MY134582A/en unknown
- 2003-01-29 TW TW092101968A patent/TWI352077B/zh active
- 2003-01-29 PE PE2003000092A patent/PE20031029A1/es not_active Application Discontinuation
- 2003-01-30 UY UY27633A patent/UY27633A1/es not_active Application Discontinuation
- 2003-01-31 AR ARP030100288A patent/AR038379A1/es not_active Application Discontinuation
2004
- 2004-07-28 EC EC2004005209A patent/ECSP045209A/es unknown
- 2004-08-30 NO NO20043612A patent/NO328929B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO328929B1 (no)	2010-06-21
PT1472251E (pt)	2005-10-31
CN100348598C (zh)	2007-11-14
PL209037B1 (pl)	2011-07-29
JP2005516067A (ja)	2005-06-02
EP1561751A1 (fr)	2005-08-10
MEP43408A (en)	2011-02-10
DE10203741A1 (de)	2003-08-14
EP1472251B1 (fr)	2005-07-20
CA2472149A1 (fr)	2003-08-07
ECSP045209A (es)	2004-09-28
RS50918B (sr)	2010-08-31
HK1082376A1 (en)	2006-05-04
JP4484522B2 (ja)	2010-06-16
KR20040081166A (ko)	2004-09-20
MXPA04007245A (es)	2004-10-29
CN1625557A (zh)	2005-06-08
AR038379A1 (es)	2005-01-12
HRP20040690A2 (en)	2005-10-31
MY134582A (en)	2007-12-31
RS65604A (sr)	2006-12-15
KR100950869B1 (ko)	2010-04-06
EP1472251A1 (fr)	2004-11-03
TWI352077B (en)	2011-11-11
ES2245443T3 (es)	2006-01-01
EA006966B1 (ru)	2006-06-30
PL369396A1 (en)	2005-04-18
TW200302817A (en)	2003-08-16
NO20043612L (no)	2004-08-30
HRP20040690B1 (en)	2012-09-30
WO2003064419A1 (fr)	2003-08-07
EA200400878A1 (ru)	2005-02-24
DE50300813D1 (de)	2005-08-25
NZ534784A (en)	2005-08-26
CA2472149C (fr)	2011-01-11
AU2003210172B2 (en)	2009-04-02
BR0307294A (pt)	2004-12-21
ATE299880T1 (de)	2005-08-15
AU2003210172C1 (en)	2009-09-24
UY27633A1 (es)	2003-08-29
UA78544C2 (uk)	2007-04-10
PE20031029A1 (es)	2004-01-27

Publication	Publication Date	Title
IL162527A0 (en)	2005-11-20	Novel fluorene carboxylic acid esters, methods forthe production thereof, and use of the same as pharmaceuticals
AU2003210172A1 (en)	2003-09-18	Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
AU2003293757A1 (en)	2004-06-23	Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
AU2003287625A1 (en)	2004-06-03	Materials and methods for the efficient production of acetate and other products
AU2003292239A1 (en)	2004-07-14	Novel carboxamides, the production and use thereof as medicaments
AU2003282094A1 (en)	2004-06-15	Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
PL375344A1 (en)	2005-11-28	Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
PL372884A1 (en)	2005-08-08	Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
PL366401A1 (en)	2005-01-24	Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
AU2003209726A1 (en)	2003-09-29	Catalyst-precursor for the production of maleic acid anhydride and method for the production thereof
PL375700A1 (en)	2005-12-12	Novel vinyl carboxylic acid derivatives and their therapeutical use
AU2003222083A1 (en)	2003-10-13	Acid and ester compounds and methods of using the same
AU2003202566A1 (en)	2003-09-04	Granulated product and process to prepare the same
ZA200409433B (en)	2005-07-14	Process for the preparation of carboxylic acid esters.
PL377755A1 (pl)	2006-02-20	Cykloalkilo-podstawione pochodne kwasów alkanowych, sposób ich wytwarzania i ich zastosowanie, jako środka leczniczego
AU2003221495A1 (en)	2003-10-08	Production of carboxylic acid amides
IL174438A0 (en)	2006-08-01	Phenylacetic acid derivative, process for producing the same, and use
TWI372143B (en)	2012-09-11	Process for the production of acetic acid
AU2003272982A1 (en)	2004-05-04	Process for the production of sulfoalkyl-containing polymers
AU2002358997A1 (en)	2004-03-19	Production of lower aliphatic carboxylic acid ester
AU2002952537A0 (en)	2002-11-21	The production of fodder
AU2003250142A1 (en)	2004-02-25	Method for the production of hydroxyalkyl carbonic acid esters
AU2002315286A1 (en)	2002-11-05	Modified polymers with a high proportion of cis-position double bonds, method for the production and use thereof
AU2002339752A1 (en)	2003-12-31	Process for the production of aliphatic carboxylic acid esters
EG23520A (en)	2006-03-22	Process of the production of carboxylic acids

Legal Events

Date	Code	Title	Description
2013-02-03	KB	Patent renewed
2017-08-31	MM9K	Patent not in force due to non-payment of renewal fees